Silphium Asset Management LTD Endo International PLC Transaction History

Silphium Asset Management LTD

  • $280 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 30, 2025
SELL
$7.3 - $18.3 $185,989 - $466,247
-25,478 Closed
0 $0
Q2 2018

Jan 30, 2025
BUY
$5.43 - $9.83 $138,345 - $250,448
25,478 New
25,478 $240 Million

About Endo International plc

ENDP Quotes by TradingView
  • Ticker ENDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 235,143,008
  • Market Cap $68.8M
  • Description
  • Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocio...
More about ENDP
Track This Portfolio

Track Silphium Asset Management LTD Portfolio

Follow Silphium Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silphium Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Silphium Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email